“FDA Proposes Reclassifying ECT Devices”

1
222

The Food and Drug Administration (FDA) is attempting to reclassify the electroconvulsive therapy (ECT) device for use in treating severe depression (MDE) or bipolar “disorder” (BPD). The device is currently a class III device and the proposal is to make it a class II device.

Article →

1 COMMENT

  1. The FDA is lost and hasn’t a clue about half of the things they approve. They also haven’t figured out yet that there is no proof anywhere that “metal illness” regardless of how it’s defined benefits greatly from the psychiatric intervention.

    Let’s label this for what it is: a torture device. Used by the moral police (mental health in all it’s ineffective, greedy forms).

    Report comment

LEAVE A REPLY